Funding Opportunity and Strategic Initiatives to Provide Enormous Opportunity for the Global AI in Genomics Market

Published: Jun 2022

The global AI in genomics market is anticipated to grow at a significant CAGR of 50.2% during the forecast period (2022-2028). Several advances conducted in the field of pharmaceutical and artificial intelligence (AI) which is likely to boost the growth of the global AI in the genomics market. For instance, in November 2020, Dell Technologies announced new Dell EMC Ready Solutions and high-performance computing(HPC), cloud service provider collaboration to accelerate AI and advanced computing innovation in healthcare, life science, and manufacturing. Moreover, it is specifically designed for bioinformatics and workload management that provides assistance to process complex genomics data faster for personalized treatment of diseases. Moreover, in March 2022, Fabric Genomics Inc. unveiled that the Broad Insitute of MIT and Harvard has selected the company to support the development and implantation of its clinical whole genome sequencing-based offerings. Under the agreement, Fabric Genomics provides AI-based platforms that are used to support the interpretation of clinical whole gnomes and generate patient reports.  

Browse the full report description of “Global AI in Genomics Market Size, Share & Trends Analysis Report, By Delivery Mode (On-Premise and Cloud-Based), By Functionality (Genome Sequencing and Gene Editing), By Application (Translational Precision Medicine, Clinical and Genomic Diagnosis, and Others), By End-User (Pharmaceutical and Biotechnology Companies, Research Centers, Academic Institutes and Government Organizations, and Others), Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/ai-in-genomics-market

Additionally, the funding provided by the government for promoting genomic sequencing is one of the major factors that boost market growth. For instance, in April 2021, the US government funded $240 million to expand the capacity for genomic sequencing. In addition, the government also allocated $400 million that is used to establish six centers of excellence in genomic epidemiology. These centers mainly focus on developing new genomics surveillance tools to better track pathogens for public health. 

Market Coverage

The market number available for – 2021-2028

Base year- 2021

Forecast period- 2021-2028

Segment Covered- 

o By Delivery Mode 

o By Functionality 

o By Application  

o By End-User

Regions Covered- 

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape- IBM Corp., Microsoft Corp., Google LLC, and NVIDIA Corp., among others.

Key questions addressed by the report

What is the market growth rate?

Which segment/region dominates the market in the base year?

Which segment/region will project the fastest growth in the market?

How has COVID-19 impacted the market?

o Recovery Timeline

o Deviation from the pre-COVID forecast

o Most affected region/segment

Who is the leader in the market?

How players are addressing challenges to sustain growth?

Where is the investment opportunity?

Global AI in Genomics Market Report by Segment

By Delivery Mode 

  • On-Premise 
  • Cloud-Based 

By Functionality 

  • Genome Sequencing 
  • Gene Editing

By Application 

  • Translational Precision Medicine 
  • Clinical and Genomic Diagnosis 
  • Others

By End-User

  • Pharmaceutical and Biotechnology Companies
  • Research Centers, Academic Institutes, and Government Organizations
  • Others

Global AI in Genomics Market Report by Region 

North America           

US

Canada

Europe

Germany

United Kingdom

France

Spain

Italy

Rest of Europe

Asia-Pacific    

China

Japan

India

Rest of Asia-Pacific

Rest of the World

Middle East & Africa 

Latin America 


To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/ai-in-genomics-market